Immatics Biotechnologies GmbH

http://www.immatics.com/
Specialises in immunotherapies specifically for cancer treatment.
Total raised: $249.93875M

Investors 3

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
28.08.2019-$75M--
04.10.2017Series E$58M--
16.07.2014Series D$45.987396...--
21.09.2010Series C$70.951354...--

Mentions in press and media 11

DateTitleDescriptionCategoryAuthorSource
17.03.2021Immatics P...Company to host conference cal...--globenewsw...
28.08.2019Celgene in...The deal includes a $75 millio...--medcitynew...
05.10.2017Term Sheet...LIFE SCIENCES $$$ Good mornin...--fortune.co...
04.10.2017Immatics R...Immatics, a leading company in...--citybizlis...
04.10.2017Immatics C...Immatics, a Tuebingen, Germany...Germany-finsmes.co...
04.10.2017Amgen help...Immatics has raised $58 millio...Biotech-fiercebiot...
04.10.2017Immatics r...Immatics today announced the c...--wellington...
16.07.2014immatics b...immatics biotechnologies GmbH,...Germany-finsmes.co...
21.11.2013With $4.2M...“Normal vaccines get cleared f...--medcitynew...
15.10.2013immatics b...immatics biotechnologies GmbH,...funding G...-finsmes.co...
Show more